LDR to DAAs according to histological subtypes in 46 patients with B-cell lymphoproliferative disorders associated with HCV infection
| . | CR, n . | PR, n . | SD, n . |
|---|---|---|---|
| All (N = 46) | 12 | 19 | 11 |
| MZLs (n = 37) | 11 | 16 | 6 |
| Splenic (n = 17) | 4 | 7 | 5 |
| Nodal (n = 1) | 1 | 0 | 0 |
| Extranodal (n = 15) | 5 | 7 | 0 |
| Leukemic (n = 4) | 1 | 2 | 1 |
| Follicular lymphoma (n = 2) | 0 | 2 | 0 |
| Lymphoplasmacytic lymphoma (n = 2) | 0 | 1 | 1 |
| Low-grade B-NHL NOS (n = 1) | 1 | 0 | 0 |
| CLL/SLL (n = 4) | 0 | 0 | 4 |
| . | CR, n . | PR, n . | SD, n . |
|---|---|---|---|
| All (N = 46) | 12 | 19 | 11 |
| MZLs (n = 37) | 11 | 16 | 6 |
| Splenic (n = 17) | 4 | 7 | 5 |
| Nodal (n = 1) | 1 | 0 | 0 |
| Extranodal (n = 15) | 5 | 7 | 0 |
| Leukemic (n = 4) | 1 | 2 | 1 |
| Follicular lymphoma (n = 2) | 0 | 2 | 0 |
| Lymphoplasmacytic lymphoma (n = 2) | 0 | 1 | 1 |
| Low-grade B-NHL NOS (n = 1) | 1 | 0 | 0 |
| CLL/SLL (n = 4) | 0 | 0 | 4 |
NOS, not otherwise specified; SD, stable disease.